mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.8 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.8 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.8 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.8 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |